This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
If you ask why you keep overspending, you're not alone. This section breaks down frequent triggers and offers concrete fixes to align spending with goals.
22,840 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A high-stakes portfolio shuffle by a famed activist investor grabbed headlines. This piece breaks down what happened,...
Anterix stock surged 140% as a major investor disclosed a multi-million dollar buy. This article breaks down the driv...
Friday's strong jobs data complicates the Fed's rate path, signaling higher borrowing costs ahead while raising quest...
The May 2026 Producer Price Index reports a sharp rise in wholesale costs, led by energy inputs, raising the odds of ...
Imagine a blockbuster SpaceX IPO that raises $75 billion and pays banks a record underwriting fee. This article break...
In a volatile market, you can still build lasting wealth with steady, high-yield dividend stocks hold. This article e...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
Hyperliquid just crossed a dramatic milestone: hyperliquid generated billion revenue across its protocol in under two...
As July looms, the idea that a stock market crash comes can rattle even seasoned investors. This guide shows how a di...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
As markets wobble, investors turn to stalwarts with decades of dividend increases. Three dividend kings that have rai...